Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02424383 · ClinicalTrials.gov registry record · NA
Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 1,005
- Enrollment target
NCT02424383 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 1,005 participants.
The verdict
NCT02424383, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,005 participants
- Enrollment target
Study Summary
The objective of this patient registry is to assess the clinical use of the Lutonix 035 DCB PTA Catheter in a heterogeneous patient population in a real world and on-label clinical application.
Interventions
- DEVICE PTA (Lutonix® 035 DCB Catheter)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,005 participants |
| Start Date | 2015-04-23 |
| Est. Completion | 2019-10-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02424383
The ClinicalTrials.gov registry entry for NCT02424383 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,005 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PTA (Lutonix® 035 DCB Catheter) is the first listed.
NCT02424383 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02424383 about?
NCT02424383 is a clinical study titled "Real-World Registry Assessing the Clinical Use of the Lutonix 035 Drug Coated Balloon Catheter". The objective of this patient registry is to assess the clinical use of the Lutonix 035 DCB PTA Catheter in a heterogeneous patient population in a real world and on-label clinical application.
What is the current status of trial NCT02424383?
This trial is currently completed. It is a NA study. The enrollment target is 1,005 participants. The study started on 2015-04-23. Estimated completion is 2019-10-21.
What interventions are being tested in trial NCT02424383?
The interventions under investigation include: PTA (Lutonix® 035 DCB Catheter) (DEVICE).
Who is sponsoring clinical trial NCT02424383?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.